Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant with Sorafenib for Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA)
Study sponsor: NovoCure Ltd. · NVCR
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2021-01-14Actual
Enrollment · participants25Actual
Source updated2024-11-14Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.